Reprogramming using microRNA-302 improves drug sensitivity in hepatocellular carcinoma cells. (Q54359406)

28 May 2018

title

Reprogramming using microRNA-302 improves drug sensitivity in hepatocellular carcinoma cells. (English)

1 reference

28 May 2018

1 reference

hepatocellular carcinoma

1 reference

13

Masaki Mori

1 reference

28 May 2018

Yuichiro Doki

12

Yuichiro Doki

1 reference

28 May 2018

Hidetoshi Eguchi

8

Hidetoshi Eguchi

1 reference

28 May 2018

Hideshi Ishii

10

Hideshi Ishii

1 reference

28 May 2018

Koji Umeshita

11

Koji Umeshita

1 reference

28 May 2018

Yoshito Tomimaru

4

Yoshito Tomimaru

1 reference

28 May 2018

Naoki Hama

5

Naoki Hama

1 reference

28 May 2018

Masamitsu Konno

9

Masamitsu Konno

1 reference

28 May 2018

Chikato Koga

1

Chikato Koga

1 reference

28 May 2018

author name string

Shogo Kobayashi

2

1 reference

28 May 2018

Hiroaki Nagano

3

1 reference

28 May 2018

Hiroshi Wada

6

1 reference

28 May 2018

Koichi Kawamoto

7

1 reference

28 May 2018

publication date

18 April 2014

1 reference

28 May 2018

Annals of Surgical Oncology

published in

1 reference

28 May 2018

volume

21 Suppl 4

1 reference

28 May 2018

page(s)

S591-600

1 reference

28 May 2018

https://scigraph.springernature.com/pub.10.1245/s10434-014-3705-7

exact match

0 references

cites work

Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Efficacy and safety of entecavir in lamivudine-refractory patients with chronic hepatitis B: randomized controlled trial in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Prediction and prevention of intrahepatic recurrence of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Chemoembolization for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Defined factors induce reprogramming of gastrointestinal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Generation of germline-competent induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Long-term culture following ES-like gene-induced reprogramming elicits an aggressive phenotype in mutated cholangiocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Reprogramming of mouse and human cells to pluripotency using mature microRNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Embryonic stem cell-specific MicroRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Embryonic stem cell-specific microRNAs promote induced pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Defined and serum-free media support undifferentiated human embryonic stem cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

miR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

mir-29 regulates Mcl-1 protein expression and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Insulin-like growth factor-binding protein 7 alters the sensitivity to interferon-based anticancer therapy in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Regulation of somatic cell reprogramming through inducible mir-302 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Overexpression of LSD1 in hepatocellular carcinoma: a latent target for the diagnosis and therapy of hepatoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

LSD1-mediated demethylation of histone H3 lysine 4 triggers Myc-induced transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Central role of c-Myc during malignant conversion in human hepatocarcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

RNAi silencing of c-Myc inhibits cell migration, invasion, and proliferation in HepG2 human hepatocellular carcinoma cell line: c-Myc silencing in hepatocellular carcinoma cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

KDM5B histone demethylase controls epithelial-mesenchymal transition of cancer cells by regulating the expression of the microRNA-200 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

MicroRNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

A novel role of miR-302/367 in reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Electroporation-mediated ex vivo gene transfer into graft not requiring injection pressure in orthotopic liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Gene transfer into the liver by plasmid injection into the portal vein combined with electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Innovative strategy for microRNA delivery in human mesenchymal stem cells via magnetic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

Fabrication and intracellular delivery of doxorubicin/carbonate apatite nanocomposites: effect on growth retardation of established colon tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3705-7

10.1245/S10434-014-3705-7

21 January 2018

Identifiers

DOI

1 reference

28 May 2018

Dimensions Publication ID

0 references

1 reference

28 May 2018